175202-91-2 Usage
Uses
Used in Pharmaceutical Industry:
3,4-Dihydro-2,2-dioxo-7-methoxycarbonyl-1-methylbenzo[2,1-c]thiazin-4-one is used as a starting material for the synthesis of other organic compounds, which can be further utilized in the development of new drugs. Its unique structure and properties make it a valuable component in the creation of pharmaceutical agents.
Used in Chemical Research:
In the chemical industry, 3,4-Dihydro-2,2-dioxo-7-methoxycarbonyl-1-methylbenzo[2,1-c]thiazin-4-one serves as a research tool, aiding scientists in understanding its properties and potential applications. It can contribute to the advancement of chemical knowledge and the discovery of new synthetic pathways or reactions.
It is crucial to handle 3,4-Dihydro-2,2-dioxo-7-methoxycarbonyl-1-methylbenzo[2,1-c]thiazin-4-one with care and adhere to safety protocols, as it may possess hazardous properties.
Check Digit Verification of cas no
The CAS Registry Mumber 175202-91-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,2,0 and 2 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 175202-91:
(8*1)+(7*7)+(6*5)+(5*2)+(4*0)+(3*2)+(2*9)+(1*1)=122
122 % 10 = 2
So 175202-91-2 is a valid CAS Registry Number.
InChI:InChI=1/C11H11NO5S/c1-12-9-5-7(11(14)17-2)3-4-8(9)10(13)6-18(12,15)16/h3-5H,6H2,1-2H3
175202-91-2Relevant academic research and scientific papers
INDOLE DERIVATIVE USED AS CRTH2 INHIBITOR
-
Paragraph 0225-0226, (2019/06/07)
The present application discloses an indole as represented by formula (I) used as a CRTH2 inhibitor, and a pharmaceutically acceptable salt or tautomer of the indole, and an application of same in treating a disease related to a CRTH2 receptor.
As CRTH2 inhibitor of indole compounds (by machine translation)
-
Paragraph 0101; 0102; 0103, (2018/05/16)
The application discloses a formula (I) as shown in CRTH2 inhibitor of indole compound or its pharmaceutically acceptable salt, and their use in the treatment with the CRTH2 receptor-related diseases in the application. (by machine translation)
